Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -69.95% is 157% below its 5-year average of -27.27%, around the middle of its 5-year range (-126.28%–18.22%).
17.27% above its 12-month average of -84.55%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -126.28%.
OPERATING MARGIN
-69.95%
OPERATING MARGIN AVG TTM
-84.55%
OPERATING MARGIN AVG 3Y
-48.54%
OPERATING MARGIN AVG 5Y
-27.27%
OPERATING MARGIN AVG 10Y
-0.97%
OPERATING MARGIN AVG 15Y
-24.16%
OPERATING MARGIN AVG 20Y
-15.88%
CURRENT VS TTM AVG
+17.27%
CURRENT VS 3Y AVG
-44.09%
CURRENT VS 5Y AVG
-156.53%
CURRENT VS 10Y AVG
-7076.35%
CURRENT VS 15Y AVG
-189.49%
CURRENT VS 20Y AVG
-340.43%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Vanda Pharmaceuticals Inc.
Market Cap
$271.81M
Operating Margin
-69.95%
TTM Avg
-84.55%
3Y Avg
-48.54%
5Y Avg
-27.27%
Market Cap
$270.80M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$266.92M
Operating Margin
-2222.45%
TTM Avg
-1882.54%
3Y Avg
-1096.29%
5Y Avg
-863.53%
Market Cap
$266.59M
Operating Margin
0.00%
TTM Avg
-1622.43%
3Y Avg
-1266.60%
5Y Avg
-841.86%
Market Cap
$265.78M
Operating Margin
-775.98%
TTM Avg
-556.52%
3Y Avg
-379.20%
5Y Avg
-295.79%
Market Cap
$264.25M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$280.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$262.92M
Operating Margin
-59.68%
TTM Avg
-91.28%
3Y Avg
-192.69%
5Y Avg
-176.13%
Market Cap
$281.54M
Operating Margin
0.00%
TTM Avg
-13.69%
3Y Avg
-1436.87%
5Y Avg
-1163.68%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. (VNDA) | $271.81M | -69.95% | -84.55% | -48.54% | -27.27% |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $270.80M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fate Therapeutics, Inc. (FATE)vs › | $266.92M | -2222.45% | -1882.54% | -1096.29% | -863.53% |
| SAB Biotherapeutics, Inc. (SABS)vs › | $266.59M | 0.00% | -1622.43% | -1266.60% | -841.86% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $265.78M | -775.98% | -556.52% | -379.20% | -295.79% |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $280.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | -59.68% | -91.28% | -192.69% | -176.13% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.54M | 0.00% | -13.69% | -1436.87% | -1163.68% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | 0.00% | 0.00% | -5599.55% | -3879.66% |
Gross Margin
92.8%
Operating Margin
-70.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -126.28% |
| 2026-03-31 | -97.11% |
| 2025-12-31 | -70.53% |
| 2025-09-30 | -55.61% |
| 2025-06-30 | -73.21% |
| 2025-03-31 | -89.02% |
| 2024-12-31 | -19.33% |
| 2024-09-30 | -23.08% |
| 2024-06-30 | -20.10% |
| 2024-03-31 | -19.46% |
| 2023-12-31 | -15.67% |
| 2023-09-30 | -15.45% |
| 2023-06-30 | -6.23% |
| 2023-03-31 | 3.21% |
| 2022-12-31 | 10.28% |
| 2022-09-30 | 5.98% |
| 2022-06-30 | 5.38% |
| 2022-03-31 | -12.74% |
| 2021-12-31 | 12.70% |
| 2021-09-30 | 15.43% |
| 2021-06-30 | 18.22% |
| 2021-03-31 | 16.50% |
| 2020-12-31 | 15.45% |
| 2020-09-30 | 12.84% |
| 2020-06-30 | 14.74% |
| 2020-03-31 | -0.22% |
| 2019-12-31 | 6.96% |
| 2019-09-30 | 18.09% |
| 2019-06-30 | 16.75% |
| 2019-03-31 | -4.37% |
| 2018-12-31 | 17.25% |
| 2018-09-30 | 12.69% |
| 2018-06-30 | 8.26% |
| 2018-03-31 | 5.60% |
| 2017-12-31 | -4.86% |
| 2017-09-30 | -11.91% |
| 2017-06-30 | -4.57% |
| 2017-03-31 | -21.13% |
| 2016-12-31 | -1.71% |
| 2016-09-30 | -1.70% |
| 2016-06-30 | -13.29% |
| 2016-03-31 | -37.51% |
| 2015-12-31 | -46.76% |
| 2015-09-30 | -33.66% |
| 2015-06-30 | -19.79% |
| 2015-03-31 | -46.47% |
| 2014-12-31 | 453.44% |
| 2014-09-30 | -9.80% |
| 2014-06-30 | -198.91% |
| 2014-03-31 | -290.69% |
| 2013-12-31 | -87.29% |
| 2013-09-30 | -62.06% |
| 2013-06-30 | -37.37% |
| 2013-03-31 | -52.29% |
| 2012-12-31 | -81.16% |
| 2012-09-30 | -65.09% |
| 2012-06-30 | -96.50% |
| 2012-03-31 | -102.16% |
| 2011-12-31 | -70.59% |
| 2011-09-30 | -41.32% |
| 2011-06-30 | -20.36% |
| 2011-03-31 | 0.09% |
| 2010-12-31 | 10.20% |
| 2010-09-30 | 10.26% |
| 2010-06-30 | 13.95% |
| 2010-03-31 | 49.49% |
| 2009-12-31 | -203.22% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | -579.02% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
